0002146896-26-000001.txt : 20260723 0002146896-26-000001.hdr.sgml : 20260723 20260722175244 ACCESSION NUMBER: 0002146896-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260723 DATE AS OF CHANGE: 20260722 EFFECTIVENESS DATE: 20260723 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Angelis Oncology, Inc. CENTRAL INDEX KEY: 0002146896 ORGANIZATION NAME: EIN: 422561307 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-591827 FILM NUMBER: 261194651 BUSINESS ADDRESS: STREET 1: 211 BELGRAVE AVE. CITY: SAN FRANCISCO STATE: CA ZIP: 94117 BUSINESS PHONE: 415-215-5586 MAIL ADDRESS: STREET 1: 211 BELGRAVE AVE. CITY: SAN FRANCISCO STATE: CA ZIP: 94117 D 1 primary_doc.xml X0708 D LIVE 0002146896 Angelis Oncology, Inc. 211 BELGRAVE AVE. SAN FRANCISCO CA CALIFORNIA 94117 415-215-5586 DELAWARE None None Corporation true 2026 Daniel Santi 211 Belgrave Ave. San Francisco CA CALIFORNIA 94117 Executive Officer Director President; Chief Executive Officer; Secretary; Treasurer Biotechnology Decline to Disclose 06b false 2026-07-10 false true false 0 Indefinite 400000 Indefinite false 1 0 0 0 false Angelis Oncology, Inc. Daniel Santi Daniel Santi CEO 2026-07-22